Business, energy, technology, markets and global industry news from Business News Today

EURneffy

PharmaDeviceNews EURneffy
Representative image of a doctor discussing needle-free allergy treatment with a child and caregiver, reflecting coverage of EURneffy 1 mg’s UK approval for pediatric anaphylaxis care.
Pharma & Biotech

Why EURneffy’s UK pediatric approval could change emergency allergy treatment for children

Find out how EURneffy 1 mg’s UK approval could change needle-free anaphylaxis treatment for young children today.

Read More
Pharma & Biotech

Can ALK-Abelló’s EURneffy launch shift real-world adoption of non-injectable adrenaline in EU schools?

EMA backs EURneffy 1 mg for pediatric anaphylaxis in EU. Discover how needle-free adrenaline could reshape allergy emergency response today.

Read More